Jyong Biotech Ltd. (MENS)

Price$2.33Cached quote
MENSNasdaq
Loading local price history

Financial charts

Net income

Total cash / debt

CashTotal debt

Financial statements

5 annual periodsNewest to oldest
20252024202320222021
Revenue$0$0$0$0—
Research & development$813,000$927,000$1.1M$1.3M—
Operating expenses$2.6M$2.1M$2.8M$2.8M—
Operating income−$2.6M−$2.1M−$2.8M−$2.8M—
EBITDA−$2.5M−$1.9M−$2.7M−$5.7M—
Net income−$4.7M−$3.0M−$4.4M−$6.6M—
Basic EPSper basic share-$0.06-$0.04-$0.06-$0.09-$0.06
Diluted EPSper diluted share-$0.06-$0.04-$0.06-$0.09-$0.06

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 20 reported holders of MENS
HolderShares held
KUO FU-FENG
25.35M
BlackRock, Inc.
260.32K
GEODE CAPITAL MANAGEMENT, LLC
68.88K
HRT FINANCIAL LP
50.42K
XTX Topco Ltd
29.07K
RENAISSANCE TECHNOLOGIES LLC
22.9K
China Universal Asset Management Co., Ltd.
12.1K
State of Wyoming
11.21K
MORGAN STANLEY
6.11K
BARCLAYS PLC
5.93K
JPMORGAN CHASE & CO
5.38K
UBS Group AG
4.05K
Mirae Asset Global Investments Co., Ltd.
3.4K
Hsu Feng-Lin
3K
Hsu Ming Tsan
3K
BNP PARIBAS FINANCIAL MARKETS
2.71K
CITIGROUP INC
2.5K
GF FUND MANAGEMENT CO. LTD.
1.56K
Tower Research Capital LLC (TRC)
1.07K
Cornerstone Financial Management LLC
234

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about MENS yet. Start the conversation.

Write the first post